Ovarian steroid cell tumor with biallelic adenomatous polyposis coli inactivation in a patient with familial adenomatous polyposis

Genes Chromosomes and Cancer

Volumn 51, Issue 3, 2012, Pages 283-289

  Hu, Patrick J ^a,b,c   Knoepp, Stewart M ^a,b   Wu, Rong ^a   Cho, Kathleen R ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; GENOMIC DNA;

ADENOMATOUS POLYP; ADULT; ARTICLE; CANCER SUSCEPTIBILITY; CASE REPORT; COLON POLYPOSIS; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; ESOPHAGOGASTRODUODENOSCOPY; FAMILIAL DISEASE; FEMALE; GENE INACTIVATION; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ILEOSTOMY; IMMUNOHISTOCHEMISTRY; INTESTINE ENDOSCOPY; OVARIAN STEROID CELL TUMOR; OVARY TUMOR; PRIORITY JOURNAL; PROTEIN LOCALIZATION; TUMOR DIAGNOSIS; VIRILIZATION;

ADENOMATOUS POLYPOSIS COLI; ADENOMATOUS POLYPOSIS COLI PROTEIN; ALLELES; BASE SEQUENCE; BETA CATENIN; CODON; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENES, DOMINANT; GENOTYPE; GRANULOSA CELL TUMOR; HUMANS; LOSS OF HETEROZYGOSITY; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; OVARIAN NEOPLASMS; WNT SIGNALING PATHWAY;

EID: 84855491859     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20953     Document Type: Article

References (37)

1. Abraham SC, Nobukawa B, Giardiello FM, Hamilton SR, Wu TT. 2000. Fundic gland polyps in familial adenomatous polyposis: Neoplasms with frequent somatic adenomatous polyposis coli gene alterations. Am J Pathol 157: 747-754.
2. Abraham SC, Wu TT, Klimstra DS, Finn LS, Lee JH, Yeo CJ, Cameron JL, Hruban RH. 2001. Distinctive molecular genetic alterations in sporadic and familial adenomatous polyposis-associated pancreatoblastomas: Frequent alterations in the APC/beta-catenin pathway and chromosome 11p. Am J Pathol 159: 1619-1627.
3. Aoki K, Taketo MM. 2007. Adenomatous polyposis coli (APC): A multi-functional tumor suppressor gene. J Cell Sci 120: 3327-3335.
4. Belchetz LA, Berk T, Bapat BV, Cohen Z, Gallinger S. 1996. Changing causes of mortality in patients with familial adenomatous polyposis. Dis Colon Rectum 39: 384-387.
5. Bertario L, Presciuttini S, Sala P, Rossetti C, Pietroiusti M. 1994. Causes of death and postsurgical survival in familial adenomatous polyposis: Results from the Italian Registry. Italian Registry of Familial Polyposis Writing Committee. Semin Surg Oncol 10: 225-234.
6. Blaker H, Sutter C, Kadmon M, Otto HF, Von Knebel-Doeberitz M, Gebert J, Helmke BM. 2004. Analysis of somatic APC mutations in rare extracolonic tumors of patients with familial adenomatous polyposis coli. Genes Chromosomes Cancer 41: 93-98.
7. Boerboom D, Paquet M, Hsieh M, Liu J, Jamin SP, Behringer RR, Sirois J, Taketo MM, Richards JS. 2005. Misregulated Wnt/beta-catenin signaling leads to ovarian granulosa cell tumor development. Cancer Res 65: 9206-9215.
8. Bonnet S, Gaujoux S, Launay P, Baudry C, Chokri I, Ragazzon B, Libe R, Rene-Corail F, Audebourg A, Vacher-Lavenu MC, Groussin L, Bertagna X, Dousset B, Bertherat J, Tissier F. 2011. Wnt/beta-catenin pathway activation in adrenocortical adenomas is frequently due to somatic CTNNB1-activating mutations, which are associated with larger and nonsecreting tumors: A study in cortisol-secreting and -nonsecreting tumors. J Clin Endocrinol Metab 96: E419-E426.
9. Curia MC, Zuckermann M, De Lellis L, Catalano T, Lattanzio R, Aceto G, Veschi S, Cama A, Otte JB, Piantelli M, Mariani-Costantini R, Cetta F, Battista P. 2008. Sporadic childhood hepatoblastomas show activation of beta-catenin, mismatch repair defects and p53 mutations. Mod Pathol 21: 7-14.
10. Ellison DW, Kocak M, Dalton J, Megahed H, Lusher ME, Ryan SL, Zhao W, Nicholson SL, Taylor RE, Bailey S, Clifford SC. 2011. Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variables. J Clin Oncol 29: 1400-1407.
11. Fearon ER. 2011. Molecular genetics of colorectal cancer. Annu Rev Pathol 6: 479-507.
12. Galle TS, Juel K, Bulow S. 1999. Causes of death in familial adenomatous polyposis. Scand J Gastroenterol 34: 808-812.
13. Garcia-Rostan G, Camp RL, Herrero A, Carcangiu ML, Rimm DL, Tallini G. 2001. Beta-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis. Am J Pathol 158: 987-996.
14. Gaujoux S, Pinson S, Gimenez-Roqueplo AP, Amar L, Ragazzon B, Launay P, Meatchi T, Libe R, Bertagna X, Audebourg A, Zucman-Rossi J, Tissier F, Bertherat J. 2010. Inactivation of the APC gene is constant in adrenocortical tumors from patients with familial adenomatous polyposis but not frequent in sporadic adrenocortical cancers. Clin Cancer Res 16: 5133-5141.
15. Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, Albertsen H, Joslyn G, Stevens J, Spirio L, Robertson M, Sargeant L, Krapcho K, Wolff E, Burt R, Hughes JP, Warrington J, McPherson J, Wasmuth J, Le Paslier D, Abderrahim H, Cohen D, Leppert M, White R. 1991. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66: 589-600.
16. Groves C, Lamlum H, Crabtree M, Williamson J, Taylor C, Bass S, Cuthbert-Heavens D, Hodgson S, Phillips R, Tomlinson I. 2002. Mutation cluster region, association between germline and somatic mutations and genotype-phenotype correlation in upper gastrointestinal familial adenomatous polyposis. Am J Pathol 160: 2055-2061.
17. Half E, Bercovich D, Rozen P. 2009. Familial adenomatous polyposis. Orphanet J Rare Dis 4: 22.
18. Hamilton SR, Liu B, Parsons RE, Papadopoulos N, Jen J, Powell SM, Krush AJ, Berk T, Cohen Z, Tetu B, Burger PC, Wood PA, Taqi F, Booker SV, Petersen GM, Offerhaus GJA, Tersmette AC, Giardiello FM, Vogelstein B, Kinzler KW. 1995. The molecular basis of Turcot's syndrome. N Engl J Med 332: 839-847.
19. Hayes MC, Scully RE. 1987. Ovarian steroid cell tumors (not otherwise specified). A clinicopathological analysis of 63 cases. Am J Surg Pathol 11: 835-845.
20. Hosogi H, Nagayama S, Kanamoto N, Yoshizawa A, Suzuki T, Nakao K, Sakai Y. 2009. Biallelic APC inactivation was responsible for functional adrenocortical adenoma in familial adenomatous polyposis with novel germline mutation of the APC gene: Report of a case. Jpn J Clin Oncol 39: 837-846.
21. Ilyas M, Tomlinson IP, Rowan A, Pignatelli M, Bodmer WF. 1997. Beta-catenin mutations in cell lines established from human colorectal cancers. Proc Natl Acad Sci USA 94: 10330-10334.
22. Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, Vogelstein B, Clevers H. 1997. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 275: 1784-1787.
23. Kurahashi H, Takami K, Oue T, Kusafuka T, Okada A, Tawa A, Okada S, Nishisho I. 1995. Biallelic inactivation of the APC gene in hepatoblastoma. Cancer Res 55: 5007-5011.
24. Lazar AJ, Tuvin D, Hajibashi S, Habeeb S, Bolshakov S, Mayordomo-Aranda E, Warneke CL, Lopez-Terrada D, Pollock RE, Lev D. 2008. Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors. Am J Pathol 173: 1518-1527.
25. Marchesa P, Fazio VW, Church JM, McGannon E. 1997. Adrenal masses in patients with familial adenomatous polyposis. Dis Colon Rectum 40: 1023-1028.
26. Miyaki M, Iijima T, Ishii R, Hishima T, Mori T, Yoshinaga K, Takami H, Kuroki T, Iwama T. 2000. Molecular evidence for multicentric development of thyroid carcinomas in patients with familial adenomatous polyposis. Am J Pathol 157: 1825-1827.
27. Miyaki M, Konishi M, Kikuchi-Yanoshita R, Enomoto M, Igari T, Tanaka K, Muraoka M, Takahashi H, Amada Y, Fukayama M, Maeda Y, Iwama T, Mishima Y, Mori T, Koike M. 1994. Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors. Cancer Res 54: 3011-3020.
28. Miyaki M, Konishi M, Kikuchi-Yanoshita R, Enomoto M, Tanaka K, Takahashi H, Muraoka M, Mori T, Konishi F, Iwama T. 1993. Coexistence of somatic and germ-line mutations of APC gene in desmoid tumors from patients with familial adenomatous polyposis. Cancer Res 53: 5079-5082.
29. Miyoshi Y, Nagase H, Ando H, Horii A, Ichii S, Nakatsuru S, Aoki T, Miki Y, Mori T, Nakamura Y. 1992. Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum Mol Genet 1: 229-233.
30. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW. 1997. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275: 1787-1790.
31. Nishisho I, Nakamura Y, Miyoshi Y, Miki Y, Ando H, Horii A, Koyama K, Utsunomiya J, Baba S, Hedge P. 1991. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 253: 665-669.
32. Scully RE. 1979. Tumors of the Ovary and Maldeveloped Gonads. Washington, D.C.: Armed Forces Institute of Pathology. p 413.
33. Segditsas S, Tomlinson I. 2006. Colorectal cancer and genetic alterations in the Wnt pathway. Oncogene 25: 7531-7537.
34. Shah NB, Lindor NM. 2010. Lower gastrointestinal tract cancer predisposition syndromes. Hematol Oncol Clin North Am 24: 1229-1252.
35. Smith TG, Clark SK, Katz DE, Reznek RH, Phillips RK. 2000. Adrenal masses are associated with familial adenomatous polyposis. Dis Colon Rectum 43: 1739-1742.
36. Stratakis CA. 2003. Genetics of adrenocortical tumors: Gatekeepers, landscapers and conductors in symphony. Trends Endocrinol Metab 14: 404-410.
37. Wakatsuki S, Sasano H, Matsui T, Nagashima K, Toyota T, Horii A. 1998. Adrenocortical tumor in a patient with familial adenomatous polyposis: a case associated with a complete inactivating mutation of the APC gene and unusual histological features. Hum Pathol 29: 302-306.